Form D · Other Health Care

SonoVascular, Inc.

Chapel Hill, NC · CIK 0001903707

Offering snapshot reported Jan 17, 2023 · SEC filing

Reported sold
$2.2M
Offering amount: $2.2M
Investors reported
26
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 23, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.1M$2.2MJan 12, 2022: $750,000.00Jan 12, 2022Jan 17, 2023: $2,195,000.00Jan 17, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$750,000 → $2,195,000
  • Reported investors1 → 26

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 17, 2023Amendment$2,195,000$1,445,000vs Jan 12, 202226SEC filing
Jan 12, 2022Initial$750,000No comparison1SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-428953

Source: Form D, filed Jan 17, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Estay Director, Executive
William N. Starling Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
510 Meadowmont Village Circle Suite 283
Chapel Hill, NC, 27517